MX9100121A - Inhibidores de proteasas asparticas - Google Patents
Inhibidores de proteasas asparticasInfo
- Publication number
- MX9100121A MX9100121A MX9100121A MX9100121A MX9100121A MX 9100121 A MX9100121 A MX 9100121A MX 9100121 A MX9100121 A MX 9100121A MX 9100121 A MX9100121 A MX 9100121A MX 9100121 A MX9100121 A MX 9100121A
- Authority
- MX
- Mexico
- Prior art keywords
- aspartical
- protease inhibitors
- protease
- inhibitors
- aspartical protease
- Prior art date
Links
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54945890A | 1990-07-06 | 1990-07-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9100121A true MX9100121A (es) | 1992-02-28 |
Family
ID=24193111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9100121A MX9100121A (es) | 1990-07-06 | 1991-07-08 | Inhibidores de proteasas asparticas |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0538383A1 (enExample) |
| JP (1) | JPH05508851A (enExample) |
| AU (1) | AU8231391A (enExample) |
| IE (1) | IE912381A1 (enExample) |
| MX (1) | MX9100121A (enExample) |
| PT (1) | PT98229A (enExample) |
| WO (1) | WO1992000956A1 (enExample) |
| ZA (1) | ZA915270B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2052907A1 (en) * | 1990-10-11 | 1992-04-12 | Joseph P. Vacca | Hiv protease inhibitors having symmetrical structure |
| ATE253050T1 (de) | 1992-03-11 | 2003-11-15 | Narhex Ltd | Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen |
| US6071895A (en) * | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
| US5888992A (en) * | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
| EP0633881B1 (en) * | 1992-03-11 | 2003-10-29 | Narhex Limited | Amine derivatives of oxo- and hydroxy-substitued hydrocarbons |
| US5559256A (en) * | 1992-07-20 | 1996-09-24 | E. R. Squibb & Sons, Inc. | Aminediol protease inhibitors |
| IL110898A0 (en) * | 1993-09-10 | 1994-11-28 | Narhex Australia Pty Ltd | Polar-substituted hydrocarbons |
| DE69524592T2 (de) * | 1994-06-10 | 2002-07-18 | Seikagaku Corp., Tokio/Tokyo | 2-Acylaminopropanolverbindung und ihre pharmazeutische Zusammensetzung |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4777286A (en) * | 1985-06-18 | 1988-10-11 | The Upjohn Company | Certain aryl or hetero-hydroxamic acid esters useful as renin inhibitors |
| US5019568A (en) * | 1987-06-18 | 1991-05-28 | Merck & Co., Inc. | Steroidal glycolipids as host resistance stimulators against viral infection |
| US4866035A (en) * | 1987-10-05 | 1989-09-12 | Merck & Co., Inc. | Dipeptidyl saccharides as host resistance enhancers in AIDS-immuno-compromised hosts and methods of use |
| US4954485A (en) * | 1987-10-20 | 1990-09-04 | Sanyo-Kokusaku Pulp Co., Ltd. | 2',3'-dideoxy-4-thio-uridine derivatives, process for their preparation and antivirus agents using them |
| IL89900A0 (en) * | 1988-04-12 | 1989-12-15 | Merck & Co Inc | Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them |
| US5023338A (en) * | 1990-03-08 | 1991-06-11 | American Home Products Corporation | Renin inhibitors |
-
1991
- 1991-07-03 EP EP91913579A patent/EP0538383A1/en not_active Withdrawn
- 1991-07-03 JP JP91512455A patent/JPH05508851A/ja active Pending
- 1991-07-03 WO PCT/US1991/004758 patent/WO1992000956A1/en not_active Ceased
- 1991-07-03 AU AU82313/91A patent/AU8231391A/en not_active Abandoned
- 1991-07-05 PT PT98229A patent/PT98229A/pt not_active Application Discontinuation
- 1991-07-08 MX MX9100121A patent/MX9100121A/es unknown
- 1991-07-08 IE IE238191A patent/IE912381A1/en unknown
- 1991-07-08 ZA ZA915270A patent/ZA915270B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT98229A (pt) | 1992-05-29 |
| EP0538383A1 (en) | 1993-04-28 |
| AU8231391A (en) | 1992-02-04 |
| JPH05508851A (ja) | 1993-12-09 |
| WO1992000956A1 (en) | 1992-01-23 |
| IE912381A1 (en) | 1992-01-15 |
| EP0538383A4 (enExample) | 1994-04-13 |
| ZA915270B (en) | 1992-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI933277A7 (fi) | Amiinidioli proteaasi-inhibiittorit | |
| FI913788A7 (fi) | Seriiniproteaasien inhibiittoreita | |
| MX9100119A (es) | Inhibidores de proteasa retroviral | |
| FI930946A7 (fi) | Kininogenasinhibitorer | |
| FI944033L (fi) | Uusia proteaaseja | |
| NO942064D0 (no) | yminhibitorer | |
| FI20012317L (fi) | Retrovirusproteaasi-inhibiittoreina käyttökelpoisia hydroksietyyliaminosulfoniamideja | |
| FI950651L (fi) | Retrovirusproteaasi-inhibiittoreina käyttökelpoisia sulfonyylialkanoyyliaminohydroksietyyliaminosulfoniamideja | |
| NO981938D0 (no) | Proteaseinhibitorer | |
| FI933303L (fi) | Adenosinkinasinhibitorer | |
| FI904101A0 (fi) | 17b-acyl-4-aza-5a-androst-1-en-3-on- som 5a-reduktasinhibitorer. | |
| FI920771A7 (fi) | Hydroksyyliamidipohjaiset kollagenaasi-inhibiittorit | |
| FI954647L (fi) | Proteaasimuunnokset | |
| BR9407782A (pt) | Inibidores de protease do HIV | |
| DK674387A (da) | Proteaseinhibitorer | |
| FI925787L (fi) | Proteolytiska enzymers sackarinderivatinhibitorer | |
| FI915819L (fi) | Hiv- proteas-inhibitorer. | |
| FI913006L (fi) | Ny trombocytaggregationsinhibitor. | |
| BR8907457A (pt) | Inibidores de interleucina-1 | |
| FI935644L (fi) | Retrovirusten proteaasi-inhibiittoreita | |
| FI895962A7 (fi) | Proteaasi-inhibiittorit | |
| MX9100120A (es) | Inhibidores de proteasas retrovirales | |
| ITTO910643A0 (it) | Procedimento di galvanostegia | |
| FI932740A7 (fi) | Dryck foer intag foere operation | |
| FI101796B1 (fi) | Uusia -glukosidaasi-inhibiittoreita |